Physician profile
Andrew Fine
NPI 1013097427
$6,840.60
in general payments reported to CMS, 2019-2025
15 companies · $4,721 in 2025
The $4,721 reported for 2025 was more than what 80% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2021: $528 · 2022: $218 · 2023: $224 · 2024: $367 · 2025: $4,721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,200 · Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,200.00 |
| Food and Beverage | $1,112.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wenzel Spine, INC. | $5,643.31 | 2019-2025 | Varilift, Esp, Varilift |
| Orthofix Medical, INC. | $280.14 | 2024-2025 | Spinal-Stim, Stim On Track, Cervical-Stim |
| Baxter Healthcare | $155.45 | 2023-2024 | Starling System, Floseal |
| Surgical Theater. INC. | $118.61 | 2025 | |
| Zap Surgical Systems, INC. | $105.32 | 2022 | |
| Depuy Synthes Sales INC. | $98.88 | 2019 | |
| Boston Scientific Corporation | $90.34 | 2019-2022 | |
| Providence Medical Technology, INC. | $85.42 | 2025 | |
| Lifenet Health | $74.45 | 2024 | Theragenesis Wound Matrix |
| Mizuho America, INC. | $71.26 | 2022 | |
| Spine Wave, INC. | $39.81 | 2025 | Salvo Spine System |
| Scilex Pharmaceuticals INC. | $21.39 | 2024 | |
| Smith+Nephew, INC. | $20.35 | 2024 | Pico |
| Abbott Laboratories | $18.08 | 2023 | Proclaim |
| Stryker Corporation | $17.79 | 2025 | Allograft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Fine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.